• Optimizing hiPSC-Derived Platelet Production with Small Mole

  2026-06-11

  This study presents an optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), integrating higher embryoid body seeding, serum-free medium, and strategic small molecule modulators. The approach shortens differentiation time, enhances yield, and significantly reduces costs, delivering new options for transfusion research and cell therapy.

• LC–MS/MS Mapping of GS-441524 Prodrug Pathways and Pharmacok

  2026-06-11

  This study introduces a sensitive LC–MS/MS method to elucidate the conversion and pharmacokinetic pathways of a novel GS-441524 prodrug (NGP-1), enhancing understanding of its bioactivation and oral bioavailability. Findings inform both mechanistic research and the rational design of anti-SARS-CoV-2 nucleoside analogs.

• Cimetidine in Research: Optimizing H2 Antagonist Assays & Mo

  2026-06-10

  Cimetidine’s unique partial agonist profile and high solubility empower advanced workflows in cancer and blood-brain barrier research. This article details experimental setups, protocol refinements, and troubleshooting strategies that leverage APExBIO’s high-purity Cimetidine to deliver reproducible, data-driven results.

• Hoechst 33342/PI Double Staining Kit: Fluorescent Apoptosis

  2026-06-10

  The Hoechst 33342/PI Double Staining Kit enables rapid, reliable detection of apoptosis and necrosis via dual fluorescence. This cell death assay kit distinguishes viable, apoptotic, and necrotic cells by chromatin condensation and membrane integrity, supporting high-confidence research workflows.

• ARCA EGFP mRNA: Reliable Fluorescence-Based Transfection Con

  2026-06-09

  This article addresses persistent challenges in mammalian cell transfection assays, providing scenario-driven guidance for using ARCA EGFP mRNA (SKU R1001) as a reproducible, sensitive, and cost-effective mRNA transfection control. By integrating real laboratory questions, numeric benchmarks, and evidence-backed best practices, it showcases how this direct-detection reporter mRNA from APExBIO strengthens assay reliability for cell viability, proliferation, and cytotoxicity workflows.

• Praeruptorin A: Mechanistic Insights for Metastasis and Infl

  2026-06-09

  Explore the advanced molecular mechanisms and translational assay strategies of Praeruptorin A, an angular pyranocoumarin compound. This article delivers in-depth analysis beyond standard reviews, highlighting critical considerations for metastasis, ferroptosis, and inflammation research.

• Optimizing Mitochondrial Assays with Tetramethylrhodamine Et

  2026-06-08

  This in-depth article addresses common challenges in measuring mitochondrial membrane potential and ROS in live-cell assays, showcasing how Tetramethylrhodamine ethyl ester perchlorate (SKU: C8197) from APExBIO provides sensitivity, reproducibility, and workflow compatibility. Researchers gain actionable insights on protocol optimization and vendor selection for robust mitochondrial bioenergetics research.

• Lactate-Driven Ran Lactylation Regulates Astrocyte Polarizat

  2026-06-08

  This study uncovers how lactate accumulation after spinal cord injury (SCI) promotes astrocyte polarization through SIRT1-regulated lactylation of the non-histone protein Ran at lysine 123. The findings clarify a metabolic-epigenetic mechanism that modulates STAT3 nuclear transport and astrocyte responses, pointing to new molecular targets for CNS repair.

• 5hmC’s Genomic Context-Dependent Roles in Rice Drought Respo

  2026-06-07

  This study provides the first single-base resolution map of 5-hydroxymethylcytosine (5hmC) in rice, revealing how its genomic distribution and dynamics regulate gene expression during drought. The findings highlight 5hmC’s unique, context-dependent impact on transcriptional plasticity and genome stability, advancing our understanding of epigenetic stress adaptation in plants.

• Applied Workflows with 3X (DYKDDDDK) Peptide for Protein Pur

  2026-06-06

  The 3X (DYKDDDDK) Peptide enables highly sensitive, interference-free purification and detection of recombinant proteins. Leveraging insights from ribosome-associated processing research, this guide delivers actionable workflows, troubleshooting, and advanced applications for maximizing the peptide's capabilities in affinity purification, immunodetection, and structural biology.

• Sulfo-Cy5 NHS Ester: Precision Protein Conjugation for Imagi

  2026-06-05

  Sulfo-Cy5 NHS ester empowers aqueous-phase protein labeling, enabling high-sensitivity fluorescence imaging even with solvent-sensitive biomolecules. This article delivers an actionable workflow, troubleshooting guidance, and insight into how Sulfo-Cy5 NHS ester advances immune microenvironment analysis in cancer research.

• Dissecting Drug-Induced Apoptosis: Improved In Vitro Evaluat

  2026-06-05

  Schwartz (2022) advances in vitro cancer drug assessment by distinguishing relative from fractional viability, clarifying how agents like pan-Bcl-2 inhibitors impact proliferation and cell death. These insights refine how apoptosis induction is measured, directly informing drug screening and mechanism-of-action studies.

• Intra- and Extracellular Dicloxacillin Activity Against S. a

  2026-06-04

  This article examines the innovative dual-model approach used to assess dicloxacillin’s intra- and extracellular antibacterial activity against Staphylococcus aureus in both in vitro and in vivo settings. The findings clarify how pharmacokinetic/pharmacodynamic indices, especially fTMIC, serve as predictors for antibiotic efficacy, providing a benchmark for future research on intracellular pathogens and therapy optimization.

• (5Z)-7-Oxozeaenol: Selective TAK1 Inhibitor for Inflammation

  2026-06-04

  (5Z)-7-Oxozeaenol is a potent, selective TAK1 inhibitor used to probe inflammatory signaling. It irreversibly blocks TAK1-mediated NF-κB and JNK/p38 MAPK pathways, attenuating COX-2 expression and inflammatory responses. Its nanomolar potency and specificity make it a critical research tool for dissecting cytokine-driven pathways in cell culture and animal models.

• Novel Allosteric PDK4 Inhibitors for Metabolic Disease Thera

  2026-06-03

  This study reports the identification of a new class of pyruvate dehydrogenase kinase 4 (PDK4) inhibitors with improved pharmacological properties. Compound 8c, in particular, demonstrates potent in vitro and in vivo activity, supporting the therapeutic targeting of PDK4 in metabolic, allergic, and proliferative diseases.

16687 records 1/1113 page Next 12345 下5页 Last page